Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus

C Lood, H Tydén, B Gullstrand, CT Nielsen… - …, 2017 - academic.oup.com
Objectives. SLE is an autoimmune disease with increased cardiovascular morbidity and
platelet activation. In the general population, increased platelet size predicts platelet …

Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus.

C Lood, H Tydén, B Gullstrand, CT Nielsen… - Rheumatology …, 2017 - europepmc.org
Objectives. SLE is an autoimmune disease with increased cardiovascular morbidity and
platelet activation. In the general population, increased platelet size predicts platelet …

Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus

C Lood, H Tydén, B Gullstrand… - Rheumatology …, 2017 - portal.research.lu.se
Objectives:. SLE is an autoimmune disease with increased cardiovascular morbidity and
platelet activation. In the general population, increased platelet size predicts platelet …

Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus

C Lood, H Tydén, B Gullstrand… - Rheumatology …, 2017 - research.regionh.dk
Objectives:. SLE is an autoimmune disease with increased cardiovascular morbidity and
platelet activation. In the general population, increased platelet size predicts platelet …

[PDF][PDF] Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus

C Lood, H Tyden, B Gullstrand, CT Nielsen… - Rheumatology, 2017 - academia.edu
Objectives. SLE is an autoimmune disease with increased cardiovascular morbidity and
platelet activation. In the general population, increased platelet size predicts platelet …

Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus.

C Lood, H Tydén, B Gullstrand, CT Nielsen… - …, 2017 - search.ebscohost.com
Objectives. SLE is an autoimmune disease with increased cardiovascular morbidity and
platelet activation. In the general population, increased platelet size predicts platelet …

[HTML][HTML] Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus

C Lood, H Tydén, B Gullstrand, CT Nielsen… - Rheumatology (Oxford …, 2017 - lup.lub.lu.se
Objectives:. SLE is an autoimmune disease with increased cardiovascular morbidity and
platelet activation. In the general population, increased platelet size predicts platelet …

Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus

C Lood, H Tydén, B Gullstrand… - Rheumatology …, 2017 - pubmed.ncbi.nlm.nih.gov
Objectives. SLE is an autoimmune disease with increased cardiovascular morbidity and
platelet activation. In the general population, increased platelet size predicts platelet …

Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus.

C Lood, H Tydén, B Gullstrand, CT Nielsen… - …, 2017 - search.ebscohost.com
Objectives. SLE is an autoimmune disease with increased cardiovascular morbidity and
platelet activation. In the general population, increased platelet size predicts platelet …